Annual ROA
-78.92%
-33.00%-71.86%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual return on assets is -78.92%, with the most recent change of -33.00% (-71.86%) on December 31, 2023.
- During the last 3 years, ENLV annual ROA has fallen by -49.62% (-169.35%).
- ENLV annual ROA is now -418.87% below its all-time high of -15.21%, reached on December 31, 2021.
Performance
ENLV ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-58.45%
+2.33%+3.83%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly return on assets is -58.45%, with the most recent change of +2.33% (+3.83%) on September 30, 2024.
- Over the past year, ENLV quarterly ROA has dropped by -10.72% (-22.46%).
- ENLV quarterly ROA is now -824.29% below its all-time high of 8.07%, reached on September 30, 2018.
Performance
ENLV Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
ENLV ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.9% | -22.5% |
| 3 y3 years | -169.3% | -34.9% |
| 5 y5 years | -105.3% | -34.9% |
ENLV ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -418.9% | at low | -288.4% | +5.6% |
| 5 y | 5-year | -418.9% | at low | -288.4% | +5.6% |
| alltime | all time | -418.9% | +78.9% | -824.3% | +89.8% |
Enlivex Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -58.45%(-3.8%) |
| Jun 2024 | - | -60.78%(-1.9%) |
| Mar 2024 | - | -61.94%(+4.8%) |
| Dec 2023 | -78.92%(+71.9%) | -59.08%(+23.8%) |
| Sep 2023 | - | -47.73%(+12.1%) |
| Jun 2023 | - | -42.56%(-1.8%) |
| Mar 2023 | - | -43.33%(+6.7%) |
| Dec 2022 | -45.92%(+201.9%) | -40.60%(+18.3%) |
| Sep 2022 | - | -34.31%(+17.2%) |
| Jun 2022 | - | -29.28%(+41.6%) |
| Mar 2022 | - | -20.68%(+37.4%) |
| Dec 2021 | -15.21%(-48.1%) | -15.05%(-20.5%) |
| Sep 2021 | - | -18.92%(-12.4%) |
| Jun 2021 | - | -21.59%(-22.2%) |
| Mar 2021 | - | -27.75%(-13.8%) |
| Dec 2020 | -29.30%(-45.2%) | -32.21%(+13.1%) |
| Sep 2020 | - | -28.47%(-14.0%) |
| Jun 2020 | - | -33.11%(+4.9%) |
| Mar 2020 | - | -31.55%(-35.6%) |
| Dec 2019 | -53.44% | -48.97%(+6.0%) |
| Sep 2019 | - | -46.21%(+15.1%) |
| Jun 2019 | - | -40.15%(-27.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -55.53%(-16.6%) |
| Dec 2018 | -38.44%(-44.4%) | -66.62%(-925.5%) |
| Sep 2018 | - | 8.07%(+5.1%) |
| Jun 2018 | - | 7.68%(-140.1%) |
| Mar 2018 | - | -19.14%(-59.3%) |
| Dec 2017 | -69.11%(-54.1%) | -46.99%(-60.6%) |
| Sep 2017 | - | -119.37%(-7.4%) |
| Jun 2017 | - | -128.86%(+11.6%) |
| Mar 2017 | - | -115.48%(+14.3%) |
| Dec 2016 | -150.72%(+101.3%) | -101.03%(+4.2%) |
| Sep 2016 | - | -96.99%(+22.1%) |
| Jun 2016 | - | -79.45%(+11.9%) |
| Mar 2016 | - | -71.03%(+16.9%) |
| Dec 2015 | -74.89%(+251.4%) | -60.74%(+26.0%) |
| Sep 2015 | - | -48.19%(+22.2%) |
| Jun 2015 | - | -39.43%(+3.8%) |
| Mar 2015 | - | -38.00%(+29.9%) |
| Dec 2014 | -21.31%(-94.3%) | -29.25%(-17.4%) |
| Sep 2014 | - | -35.42%(-68.7%) |
| Jun 2014 | - | -113.27%(-80.2%) |
| Mar 2014 | - | -572.55%(+58.3%) |
| Dec 2013 | -374.18%(+154.9%) | -361.76% |
| Dec 2012 | -146.79% | - |
FAQ
- What is Enlivex Therapeutics annual return on assets?
- What is the all time high annual ROA for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual ROA year-on-year change?
- What is Enlivex Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly ROA year-on-year change?
What is Enlivex Therapeutics annual return on assets?
The current annual ROA of ENLV is -78.92%
What is the all time high annual ROA for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual return on assets is -15.21%
What is Enlivex Therapeutics annual ROA year-on-year change?
Over the past year, ENLV annual return on assets has changed by -33.00% (-71.86%)
What is Enlivex Therapeutics quarterly return on assets?
The current quarterly ROA of ENLV is -58.45%
What is the all time high quarterly ROA for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly return on assets is 8.07%
What is Enlivex Therapeutics quarterly ROA year-on-year change?
Over the past year, ENLV quarterly return on assets has changed by -10.72% (-22.46%)